Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations
Open Access
- 1 March 2000
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 37 (3) , 168-176
- https://doi.org/10.1136/jmg.37.3.168
Abstract
Rubinstein-Taybi syndrome (RTS) is a malformation syndrome characterised by facial abnormalities, broad thumbs, broad big toes, and mental retardation. In a subset of RTS patients, microdeletions, translocations, and inversions involving chromosome band 16p13.3 can be detected. We have previously shown that disruption of the human CREB binding protein (CREBBP orCBP) gene, either by these gross chromosomal rearrangements or by point mutations, leads to RTS. CBP is a large nuclear protein involved in transcription regulation, chromatin remodelling, and the integration of several different signal transduction pathways. Here we report diagnostic analysis of CBP in 194 RTS patients, divided into several subsets. In one case the mother is also suspect of having RTS. Analyses of the entireCBP gene by the protein truncation test showed 4/37 truncating mutations. Two point mutations, one 11 bp deletion, and one mutation affecting the splicing of the second exon were detected by subsequent sequencing. Screening theCBP gene for larger deletions, by using different cosmid probes in FISH, showed 14/171 microdeletions. Using five cosmid probes that contain the entire gene, we found 8/89 microdeletions of which 4/8 were 5′ or interstitial. This last subset of microdeletions would not have been detected using the commonly used 3′ probe RT1, showing the necessity of using all five probes.Keywords
This publication has 41 references indexed in Scilit:
- Splicing Defects in the Ataxia-Telangiectasia Gene, ATM: Underlying Mutations and ConsequencesAmerican Journal of Human Genetics, 1999
- Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16)Leukemia, 1997
- Submicroscopic deletions at 16p13.3 in Rubinstein-Taybi syndrome: frequency and clinical manifestations in a North American population.Journal of Medical Genetics, 1997
- A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear ReceptorsCell, 1996
- Submicroscopic deletion of chromosome region 16p13.3 in a Japanese patient with Rubinstein‐Taybi syndromeAmerican Journal of Medical Genetics, 1994
- Apparent dominant transmission of the Rubinstein‐Taybi syndromeAmerican Journal of Medical Genetics, 1993
- Tentative assignment of a locus for Rubinstein‐Taybi syndrome to 16p13.3 by a de novo reciprocal translocation, t(7;16)(q34;p13.3)American Journal of Medical Genetics, 1992
- Confirmation of assigment of a locus for rubinstein‐taybi syndrome gene to 16p13.3American Journal of Medical Genetics, 1992
- Rubinstein‐Taybi syndrome with de novo reciprocal translocation t(2;16) (p13.3; p13.3)American Journal of Medical Genetics, 1991
- Rapid subchromosomal localization of cosmids by nonradioactive in situ hybridizationCytogenetic and Genome Research, 1990